4-[2-(3,5-Dihydroxyphenyl)ethenyl]benzene-1,2-diol
Internal ID | ed523cce-1847-46f6-ba47-980154b268ac |
Taxonomy | Phenylpropanoids and polyketides > Stilbenes |
IUPAC Name | 4-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol |
SMILES (Canonical) | C1=CC(=C(C=C1C=CC2=CC(=CC(=C2)O)O)O)O |
SMILES (Isomeric) | C1=CC(=C(C=C1C=CC2=CC(=CC(=C2)O)O)O)O |
InChI | InChI=1S/C14H12O4/c15-11-5-10(6-12(16)8-11)2-1-9-3-4-13(17)14(18)7-9/h1-8,15-18H |
InChI Key | CDRPUGZCRXZLFL-UHFFFAOYSA-N |
Popularity | 716 references in papers |
Molecular Formula | C14H12O4 |
Molecular Weight | 244.24 g/mol |
Exact Mass | 244.07355886 g/mol |
Topological Polar Surface Area (TPSA) | 80.90 Ų |
XlogP | 2.90 |
Atomic LogP (AlogP) | 2.68 |
H-Bond Acceptor | 4 |
H-Bond Donor | 4 |
Rotatable Bonds | 2 |
Astringenin;trans-Piceatannol |
MLS003171221 |
3,3',4',5-tetrahydroxystilbene |
PICESTANNOL |
Kinome_2842 |
KBioGR_000460 |
KBioSS_000460 |
CHEMBL1972346 |
KBio2_000460 |
KBio2_003028 |
There are more than 10 synonyms. If you wish to see them all click here. |
![2D Structure of 4-[2-(3,5-Dihydroxyphenyl)ethenyl]benzene-1,2-diol 2D Structure of 4-[2-(3,5-Dihydroxyphenyl)ethenyl]benzene-1,2-diol](https://plantaedb.com/storage/docs/compounds/2023/07/4-2-35-dihydroxyphenylethenylbenzene-12-diol.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9403 | 94.03% |
Caco-2 | + | 0.7659 | 76.59% |
Blood Brain Barrier | - | 0.7000 | 70.00% |
Human oral bioavailability | - | 0.5857 | 58.57% |
Subcellular localzation | Mitochondria | 0.5195 | 51.95% |
OATP2B1 inhibitior | - | 0.6931 | 69.31% |
OATP1B1 inhibitior | + | 0.9789 | 97.89% |
OATP1B3 inhibitior | + | 0.9799 | 97.99% |
MATE1 inhibitior | - | 0.9000 | 90.00% |
OCT2 inhibitior | - | 0.9088 | 90.88% |
BSEP inhibitior | - | 0.6653 | 66.53% |
P-glycoprotein inhibitior | - | 0.9568 | 95.68% |
P-glycoprotein substrate | - | 0.9936 | 99.36% |
CYP3A4 substrate | - | 0.7238 | 72.38% |
CYP2C9 substrate | - | 0.5963 | 59.63% |
CYP2D6 substrate | - | 0.7204 | 72.04% |
CYP3A4 inhibition | + | 0.5427 | 54.27% |
CYP2C9 inhibition | + | 0.6182 | 61.82% |
CYP2C19 inhibition | - | 0.9026 | 90.26% |
CYP2D6 inhibition | - | 0.9231 | 92.31% |
CYP1A2 inhibition | + | 0.9107 | 91.07% |
CYP2C8 inhibition | - | 0.6100 | 61.00% |
CYP inhibitory promiscuity | + | 0.7651 | 76.51% |
UGT catelyzed | + | 0.7000 | 70.00% |
Carcinogenicity (binary) | - | 0.7723 | 77.23% |
Carcinogenicity (trinary) | Non-required | 0.5596 | 55.96% |
Eye corrosion | - | 0.9698 | 96.98% |
Eye irritation | + | 0.9970 | 99.70% |
Skin irritation | + | 0.6089 | 60.89% |
Skin corrosion | - | 0.5875 | 58.75% |
Ames mutagenesis | - | 0.6200 | 62.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.7864 | 78.64% |
Micronuclear | + | 0.7400 | 74.00% |
Hepatotoxicity | - | 0.5964 | 59.64% |
skin sensitisation | + | 0.9376 | 93.76% |
Respiratory toxicity | - | 0.6667 | 66.67% |
Reproductive toxicity | + | 0.5222 | 52.22% |
Mitochondrial toxicity | - | 0.7250 | 72.50% |
Nephrotoxicity | - | 0.5896 | 58.96% |
Acute Oral Toxicity (c) | III | 0.7909 | 79.09% |
Estrogen receptor binding | + | 0.9138 | 91.38% |
Androgen receptor binding | + | 0.8411 | 84.11% |
Thyroid receptor binding | + | 0.7823 | 78.23% |
Glucocorticoid receptor binding | + | 0.8424 | 84.24% |
Aromatase binding | + | 0.9377 | 93.77% |
PPAR gamma | + | 0.9167 | 91.67% |
Honey bee toxicity | - | 0.8277 | 82.77% |
Biodegradation | - | 0.8250 | 82.50% |
Crustacea aquatic toxicity | + | 0.5900 | 59.00% |
Fish aquatic toxicity | + | 0.9851 | 98.51% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL5903 | Q04771 | Activin receptor type-1 |
501.19 nM |
Ki |
via CMAUP
|
CHEMBL4247 | Q9UM73 | ALK tyrosine kinase receptor |
251.19 nM |
Ki |
via CMAUP
|
CHEMBL2903 | P16050 | Arachidonate 15-lipoxygenase |
794.3 nM |
Potency |
via Super-PRED
|
CHEMBL215 | P09917 | Arachidonate 5-lipoxygenase |
240 nM |
IC50 |
via Super-PRED
|
CHEMBL2637 | P53779 | c-Jun N-terminal kinase 3 |
50.12 nM |
Ki |
via CMAUP
|
CHEMBL5073 | Q8IU85 | CaM kinase I delta |
501.19 nM |
Ki |
via CMAUP
|
CHEMBL4147 | Q9UQM7 | CaM kinase II alpha |
794.33 nM |
Ki |
via CMAUP
|
CHEMBL5284 | Q96RR4 | CaM-kinase kinase beta |
63.1 nM |
Ki |
via CMAUP
|
CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit |
1584.89 nM |
Ki |
via CMAUP
|
CHEMBL2793 | P48729 | Casein kinase I alpha |
316.23 nM |
Ki |
via CMAUP
|
CHEMBL5719 | P49336 | Cell division protein kinase 8 |
251.19 nM |
Ki |
via CMAUP
|
CHEMBL4225 | P49760 | Dual specificity protein kinase CLK2 |
501.19 nM |
Ki |
via CMAUP
|
CHEMBL5543 | Q9Y463 | Dual specificity tyrosine-phosphorylation-regulated kinase 1B |
100 nM |
Ki |
via CMAUP
|
CHEMBL2292 | Q13627 | Dual-specificity tyrosine-phosphorylation regulated kinase 1A |
31.62 nM |
Ki |
via CMAUP
|
CHEMBL3650 | P11362 | Fibroblast growth factor receptor 1 |
630.96 nM |
Ki |
via CMAUP
|
CHEMBL2695 | Q05397 | Focal adhesion kinase 1 |
794.33 nM |
Ki |
via CMAUP
|
CHEMBL5678 | P34947 | G protein-coupled receptor kinase 5 |
501.19 nM |
Ki |
via CMAUP
|
CHEMBL2850 | P49840 | Glycogen synthase kinase-3 alpha |
3162.28 nM |
Ki |
via CMAUP
|
CHEMBL262 | P49841 | Glycogen synthase kinase-3 beta |
1000 nM |
Ki |
via CMAUP
|
CHEMBL2424 | Q04760 | Glyoxalase I |
760 nM |
IC50 |
via Super-PRED
|
CHEMBL3529 | Q14164 | Inhibitor of nuclear factor kappa B kinase epsilon subunit |
398.11 nM |
Ki |
via CMAUP
|
CHEMBL1075104 | Q5S007 | Leucine-rich repeat serine/threonine-protein kinase 2 |
501.19 nM |
Ki |
via CMAUP
|
CHEMBL5627 | P29376 | Leukocyte tyrosine kinase receptor |
316.23 nM |
Ki |
via CMAUP
|
CHEMBL5754 | Q96L34 | MAP/microtubule affinity-regulating kinase 4 |
50.12 nM |
Ki |
via CMAUP
|
CHEMBL4578 | Q14680 | Maternal embryonic leucine zipper kinase |
79.43 nM |
Ki |
via CMAUP
|
CHEMBL2873 | Q02779 | Mitogen-activated protein kinase kinase kinase 10 |
100 nM |
Ki |
via CMAUP
|
CHEMBL6166 | O95819 | Mitogen-activated protein kinase kinase kinase kinase 4 |
501.19 nM |
Ki |
via CMAUP
|
CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha |
1000 nM |
Ki |
via CMAUP
|
CHEMBL1293235 | P02545 | Prelamin-A/C |
56.2 nM |
Potency |
via Super-PRED
|
CHEMBL3920 | Q04759 | Protein kinase C theta |
794.33 nM |
Ki |
via CMAUP
|
CHEMBL5568 | P08922 | Proto-oncogene tyrosine-protein kinase ROS |
794.33 nM |
Ki |
via CMAUP
|
CHEMBL3231 | Q13464 | Rho-associated protein kinase 1 |
2511.89 nM |
Ki |
via CMAUP
|
CHEMBL2973 | O75116 | Rho-associated protein kinase 2 |
125.89 nM |
Ki |
via CMAUP
|
CHEMBL2345 | P51812 | Ribosomal protein S6 kinase alpha 3 |
1584.89 nM |
Ki |
via CMAUP
|
CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 |
251.19 nM |
Ki |
via CMAUP
|
CHEMBL4708 | Q13188 | Serine/threonine-protein kinase MST2 |
630.96 nM |
Ki |
via CMAUP
|
CHEMBL2147 | P11309 | Serine/threonine-protein kinase PIM1 |
2511.89 nM |
Ki |
via CMAUP
|
CHEMBL5818 | P51817 | Serine/threonine-protein kinase PRKX |
630.96 nM |
Ki |
via CMAUP
|
CHEMBL5794 | Q9HBY8 | Serine/threonine-protein kinase Sgk2 |
316.23 nM |
Ki |
via CMAUP
|
CHEMBL5699 | Q9H0K1 | Serine/threonine-protein kinase SIK2 |
100 nM |
Ki |
via CMAUP
|
CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 |
1000 nM |
Ki |
via CMAUP
|
CHEMBL5408 | Q9UHD2 | Serine/threonine-protein kinase TBK1 |
630.96 nM |
Ki |
via CMAUP
|
CHEMBL4599 | Q07912 | Tyrosine kinase non-receptor protein 2 |
630.96 nM |
Ki |
via CMAUP
|
CHEMBL5251 | Q06187 | Tyrosine-protein kinase BTK |
630.96 nM |
Ki |
via CMAUP
|
CHEMBL3234 | P08631 | Tyrosine-protein kinase HCK |
398.11 nM |
Ki |
via CMAUP
|
CHEMBL2971 | O60674 | Tyrosine-protein kinase JAK2 |
794.33 nM |
Ki |
via CMAUP
|
CHEMBL2148 | P52333 | Tyrosine-protein kinase JAK3 |
1000 nM |
Ki |
via CMAUP
|
CHEMBL2041 | P07949 | Tyrosine-protein kinase receptor RET |
398.11 nM |
Ki |
via CMAUP
|
CHEMBL5314 | Q06418 | Tyrosine-protein kinase receptor TYRO3 |
79.43 nM |
Ki |
via CMAUP
|
CHEMBL1868 | P17948 | Vascular endothelial growth factor receptor 1 |
501.19 nM |
Ki |
via CMAUP
|
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL1951 | P21397 | Monoamine oxidase A | 98.80% | 91.49% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.61% | 91.11% |
CHEMBL3194 | P02766 | Transthyretin | 96.88% | 90.71% |
CHEMBL1929 | P47989 | Xanthine dehydrogenase | 93.27% | 96.12% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 89.51% | 95.56% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 87.81% | 96.00% |
CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 87.53% | 99.15% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 86.72% | 86.33% |
CHEMBL2085 | P14174 | Macrophage migration inhibitory factor | 83.75% | 80.78% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 81.78% | 89.00% |
CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 81.33% | 91.71% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 80.93% | 94.45% |
CHEMBL3401 | O75469 | Pregnane X receptor | 80.66% | 94.73% |
CHEMBL4208 | P20618 | Proteasome component C5 | 80.40% | 90.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
PubChem | 4813 |
NPASS | NPC105727 |
ChEMBL | CHEMBL1972346 |
LOTUS | LTS0094372 |
wikiData | Q27164196 |